| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 201.66M | — |
| Operating expense | — | — |
| Net income | 2.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NG9.F returned +147.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +33.3% |
| 1 year | +147.6% |
| 5 years | -66.7% |
| 10 years | +97.9% |
| All-time high | €44.00 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in NG9.F would be worth today ›No. NeoGenomics, Inc. has not paid a dividend in the past 12 months.
NeoGenomics, Inc. is part of the Healthcare sector.
NeoGenomics, Inc. has a market cap of 1.78B EUR, based on the latest quote.
NeoGenomics, Inc. is scheduled to report earnings on Oct 27, 2026.
